Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/nep.13786 http://scihub22266oqcxt.onion/10.1111/nep.13786 32951300!7536982!32951300     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32951300&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nephrology+(Carlton) 2020 ; 25 (12): 933-936 Nephropedia Template TP {{tp|p=32951300|t=2020. Case of "relapsing" COVID-19 in a kidney transplant recipient |pdf=|usr=}}{{32951300}} gab.com Text Case of "relapsing" COVID-19 in a kidney transplant recipient JO: Nephrology (Carlton) http://www.kidney.de/pget.php?&tw=1&pmid=32951300 #FOAvip Clinical outcomes of COVID-19 vary considerably between patients. Little was known about the clinical course and optimal management of immunosuppressed patients infected with SARS-CoV-2. We report a kidney transplant recipient with COVID-19 who presented with pneumonitis and acute kidney injury (AKI). She improved after reduction of immunosuppressive treatment and had two consecutive negative reverse transcription polymerase chain reaction (RT-PCR) tests. Her respiratory tract samples turned positive again afterwards, and she was treated with lopinavir-ritonavir. She had satisfactory virological and clinical response after a prolonged disease course. This case illustrates the risk of relapse or persisting shedding of SARS-CoV-2 in immunosuppressed patients, the important role of viral load monitoring in management, the challenges in balancing the risks of COVID-19 progression and transplant rejection, and the pharmacokinetic interaction between immunosuppressive and antiviral medications. Twit Text FOAVip Case of "relapsing" COVID-19 in a kidney transplant recipient ????Nephrology (Carlton) http://www.kidney.de/pget.php?&tw=1&pmid=32951300 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32951300 #FOAvip English Wikipedia <ref>{{Cite pmid|32951300}}</ref> Case of "relapsing" COVID-19 in a kidney transplant recipient #MMPMID32951300 Ma BM; Hung IFN; Chan GCW; Tam AR; Chan SSK; Wong BCK; Fukuda K; Ohno T; Yuen KY; Chan TM Nephrology (Carlton) 2020[Dec]; 25 (12): 933-936 PMID32951300show ga Clinical outcomes of COVID-19 vary considerably between patients. Little was known about the clinical course and optimal management of immunosuppressed patients infected with SARS-CoV-2. We report a kidney transplant recipient with COVID-19 who presented with pneumonitis and acute kidney injury (AKI). She improved after reduction of immunosuppressive treatment and had two consecutive negative reverse transcription polymerase chain reaction (RT-PCR) tests. Her respiratory tract samples turned positive again afterwards, and she was treated with lopinavir-ritonavir. She had satisfactory virological and clinical response after a prolonged disease course. This case illustrates the risk of relapse or persisting shedding of SARS-CoV-2 in immunosuppressed patients, the important role of viral load monitoring in management, the challenges in balancing the risks of COVID-19 progression and transplant rejection, and the pharmacokinetic interaction between immunosuppressive and antiviral medications. |*Kidney Transplantation[MESH] |*SARS-CoV-2[MESH] |Adult[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*complications/immunology[MESH] |Female[MESH] |Humans[MESH]Case of "relapsing" COVID-19 in a kidney transplant recipient (epmc).pdf DeepDyve Pubget Overpricing